These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 14984232

  • 21. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ, TOPMAT-MIG-201(TOP-CHROME) Study Group.
    Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
    [Abstract] [Full Text] [Related]

  • 22. Rizatriptan combined with rofecoxib vs. rizatriptan for the acute treatment of migraine: an open label pilot study.
    Krymchantowski AV, Barbosa JS.
    Cephalalgia; 2002 May; 22(4):309-12. PubMed ID: 12100094
    [Abstract] [Full Text] [Related]

  • 23. In-patient versus out-patient withdrawal programmes for medication overuse headache: a 2-year randomized trial.
    Créac'h C, Frappe P, Cancade M, Laurent B, Peyron R, Demarquay G, Navez M.
    Cephalalgia; 2011 Aug; 31(11):1189-98. PubMed ID: 21700646
    [Abstract] [Full Text] [Related]

  • 24. Prednisone for the treatment of withdrawal headache in patients with medication overuse headache: a randomized, double-blind, placebo-controlled study.
    Rabe K, Pageler L, Gaul C, Lampl C, Kraya T, Foerderreuther S, Diener HC, Katsarava Z.
    Cephalalgia; 2013 Feb; 33(3):202-7. PubMed ID: 23093541
    [Abstract] [Full Text] [Related]

  • 25. Prednisone vs. placebo in withdrawal therapy following medication overuse headache.
    Pageler L, Katsarava Z, Diener HC, Limmroth V.
    Cephalalgia; 2008 Feb; 28(2):152-6. PubMed ID: 18039339
    [Abstract] [Full Text] [Related]

  • 26. Overuse of symptomatic medications among chronic (transformed) migraine patients: profile of drug consumption.
    Krymchantowski AV.
    Arq Neuropsiquiatr; 2003 Mar; 61(1):43-7. PubMed ID: 12715017
    [Abstract] [Full Text] [Related]

  • 27. The efficacy of withdrawal therapy in subjects with chronic daily headache and medication overuse following prophylaxis with topiramate and amitriptyline.
    Valguarnera F, Tanganelli P.
    Neurol Sci; 2010 Jun; 31 Suppl 1():S175-7. PubMed ID: 20464616
    [Abstract] [Full Text] [Related]

  • 28. Treatment of withdrawal headache in patients with medication overuse headache: a pilot study.
    Cevoli S, Giannini G, Favoni V, Terlizzi R, Sancisi E, Nicodemo M, Zanigni S, Bacchi Reggiani ML, Pierangeli G, Cortelli P.
    J Headache Pain; 2017 Dec; 18(1):56. PubMed ID: 28500492
    [Abstract] [Full Text] [Related]

  • 29. Disability in chronic migraine patients with medication overuse: treatment effects at 1-year follow-up.
    Grazzi L, Andrasik F, D'Amico D, Usai S, Kass S, Bussone G.
    Headache; 2004 Dec; 44(7):678-83. PubMed ID: 15209690
    [Abstract] [Full Text] [Related]

  • 30. Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS).
    Freitag FG, Finlayson G, Rapoport AM, Elkind AH, Diamond ML, Unger JR, Fisher AC, Armstrong RB, Hulihan JF, Greenberg SJ, AIMS Investigators.
    Headache; 2007 Apr; 47(4):519-30. PubMed ID: 17445101
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Detoxification of medication-overuse headache by a multidisciplinary treatment programme is highly effective: a comparison of two consecutive treatment methods in an open-label design.
    Munksgaard SB, Bendtsen L, Jensen RH.
    Cephalalgia; 2012 Aug; 32(11):834-44. PubMed ID: 22751965
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Looking forward: the expanding utility of sumatriptan and naratriptan.
    Cady R.
    Cephalalgia; 2001 Aug; 21 Suppl 1():35-8. PubMed ID: 11678821
    [No Abstract] [Full Text] [Related]

  • 37. Naratriptan in the short-term prophylaxis of pure menstrual migraine.
    Moschiano F, Allais G, Grazzi L, Usai S, Benedetto C, D'Amico D, Roncolato M, Bussone G.
    Neurol Sci; 2005 May; 26 Suppl 2():s162-6. PubMed ID: 15926020
    [Abstract] [Full Text] [Related]

  • 38. Glutamate levels in cerebrospinal fluid and triptans overuse in chronic migraine.
    Vieira DS, Naffah-Mazzacoratti Mda G, Zukerman E, Senne Soares CA, Cavalheiro EA, Peres MF.
    Headache; 2007 Jun; 47(6):842-7. PubMed ID: 17578532
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Complete withdrawal is the most feasible treatment for medication-overuse headache: A randomized controlled open-label trial.
    Engelstoft IMS, Carlsen LN, Munksgaard SB, Nielsen M, Jensen RH, Bendtsen L.
    Eur J Pain; 2019 Jul; 23(6):1162-1170. PubMed ID: 30793412
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.